| [February 15, 2012] |
 |
Research and Markets: Nanotechnology for Drug Delivery - Nanocarriers Will Account For 40% of a $136 Billion Nanotechnology-Enabled Drug Delivery Market By 2021
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/e57396/nanotechnology_for)
has announced the addition of the "Nanotechnology
for Drug Delivery - Global Market for Nanocarriers" report to their
offering.
Nanocarriers set to be 40% of NDD market by 2021
Cientifica sees a 60/40 market split between nanocrystals and
nanocarriers
Nanocarriers will account or 40% of a $136 billion
nanotechnology-enabled drug delivery market by 2021 according to new
research published by Cientifica in its report, Nanotechnology for Drug
Delivery: Global Market for Nanocarriers.
The author forecasts that the total market size in 2021 to be US$136
billion, with a 60/40 split between nanocrystals and nanocarriers
respectively, although developing new targeted delivery mechanisms may
allow more value to be created for companies and entrepreneurs, said Tim
Harper, CEO of Cientifica Ltd.
Of the 10 nanocarrier technologies studied, liposomes and gold
nanocarriers account for 45% of the total addressable market. Liposomes
will offer the largest addressable market ($15 billion) in 2021 while
gold nanocarriers will see the highest compound annual growth rate
(CAGR)53.8%in the next decade.
It's the equivalent of using a nuclear bomb to eliminate just a handful
of enemies, said Harper. In theory, as long as the nanocarrier is
designed specifically enough, it should be possible to deliver all of
the drug to the target site whilst leaving healthy cells unaffected.
This greatly reduces treatment time, costs and unwanted side effects.
The healthcare market is changing. We are seeing a paradigm shift away
from blockbusters and a one-size fits all' approach to a more
personalised medicine based on an individual's unique genome and immune
response. The more scientists learn about the molecular causes for
disease the more targeted and effective nanotechnology-enabled drug
delivery therapies will become, said Harper.
For more information visit http://www.researchandmarkets.com/research/e57396/nanotechnology_for
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
